HEPCLUDEX
LIVE

Serial Number

79279863

Owner

MYR GmbH

Attorney

Megan K. Bowen

Filing Date

Dec 27, 2019

Add to watchlist:

No watchlists yet
View on USPTO

HEPCLUDEX Trademark

Serial Number: 79279863 • Registration: 6235919

HEPCLUDEX is a trademark filed by MYR GmbH on December 27, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

MYR GmbH (9 trademarks)

Martinsried 82152 , DE

Entity Type: 27

Trademark Details

Filing Date

December 27, 2019

Registration Date

January 5, 2021

Published for Opposition

October 20, 2020

Goods & Services

Pharmaceutical and veterinary preparations in the nature of diagnostic preparations for veterinary and medical purposes; biological preparations for medical purposes, namely, for the treatment of cancer; biological preparations for veterinary purposes, namely, for the treatment of intestinal bacteria; biochemical preparations for medical purposes, namely, for treating chemical imbalances; biochemical preparations for veterinary purposes, namely, nucleic acid sequences and chemical reagents for veterinary purposes; chemical preparations for medical purposes, namely, for diagnosis of pregnancy; chemical preparations for veterinary purposes in the nature of chemical reagents for veterinary purposes; medicines for human purposes, namely, for treating intestinal disorders; medicines for veterinary purposes, namely, for treating intestinal disorders; pharmaceutical preparations for the treatment of hepatic diseases or disorders; pharmaceutical preparations for the treatment of hepatitis B; pharmaceutical preparations for the treatment of hepatitis D; pharmaceutical preparations for the treatment of dyslipidemia; pharmaceutical preparations for the treatment of nonalcoholic steatohepatitis (NASH); pharmaceutical preparations for the treatment of primary biliary cholangitis (PBC); pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of inflammatory diseases inhibiting sodium-taurocholate co-transporting polypeptide (NTCP); pharmaceutical preparations for the treatment of metabolic diseases; and pharmaceutical preparations for the treatment of metabolic diseases inhibiting sodium-taurocholate co-transporting polypeptide (NTCP)

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 5, 2026 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 12, 2023 ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 27, 2022 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Nov 6, 2021 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Oct 2, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
May 2, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 8, 2021 FICS
FINAL DISPOSITION PROCESSED
Apr 8, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 5, 2021 FICR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Mar 1, 2021 CORR
CORRECTION TRANSACTION RECEIVED FROM IB
Feb 20, 2021 CRCV
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 22, 2021 ADCH
REGISTERED-PRINCIPAL REGISTER
Jan 5, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 20, 2020 NPUB
PUBLISHED FOR OPPOSITION
Oct 20, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Oct 18, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 30, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 30, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 30, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 16, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 26, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 25, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 25, 2020 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 17, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 17, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 17, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 17, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 17, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 17, 2020 COAR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 24, 2020 ADCH
REFUSAL PROCESSED BY IB
May 1, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 13, 2020 RFCS
REFUSAL PROCESSED BY MPU
Apr 13, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 26, 2020 RFCR
NON-FINAL ACTION WRITTEN
Mar 25, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 21, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 6, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 2, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 27, 2020 REPR